These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Corticosteroids for the treatment of Duchenne muscular dystrophy. Matthews E; Brassington R; Kuntzer T; Jichi F; Manzur AY Cochrane Database Syst Rev; 2016 May; 2016(5):CD003725. PubMed ID: 27149418 [TBL] [Abstract][Full Text] [Related]
5. Bone-modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis. Adams A; Jakob T; Huth A; Monsef I; Ernst M; Kopp M; Caro-Valenzuela J; Wöckel A; Skoetz N Cochrane Database Syst Rev; 2024 Jul; 7(7):CD013451. PubMed ID: 38979716 [TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates for osteoporosis in people with cystic fibrosis. Jeffery TC; Chang AB; Conwell LS Cochrane Database Syst Rev; 2023 Jan; 1(1):CD002010. PubMed ID: 36625789 [TBL] [Abstract][Full Text] [Related]
7. Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy. Bourke JP; Bueser T; Quinlivan R Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009068. PubMed ID: 30326162 [TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate use in children with cerebral palsy. Hurley T; Zareen Z; Stewart P; McDonnell C; McDonald D; Molloy E Cochrane Database Syst Rev; 2021 Jul; 7(7):CD012756. PubMed ID: 34224134 [TBL] [Abstract][Full Text] [Related]
9. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Wells GA; Hsieh SC; Zheng C; Peterson J; Tugwell P; Liu W Cochrane Database Syst Rev; 2022 May; 5(5):CD004523. PubMed ID: 35502787 [TBL] [Abstract][Full Text] [Related]
10. A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures. Davis S; Martyn-St James M; Sanderson J; Stevens J; Goka E; Rawdin A; Sadler S; Wong R; Campbell F; Stevenson M; Strong M; Selby P; Gittoes N Health Technol Assess; 2016 Oct; 20(78):1-406. PubMed ID: 27801641 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for the prevention of insufficiency fractures and avascular necrosis associated with pelvic radiotherapy in adults. van den Blink QU; Garcez K; Henson CC; Davidson SE; Higham CE Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010604. PubMed ID: 29683475 [TBL] [Abstract][Full Text] [Related]
12. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial. Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of vitamin D in relation to bone health. Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161 [TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Manzur AY; Kuntzer T; Pike M; Swan A Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031 [TBL] [Abstract][Full Text] [Related]
15. The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy. Sbrocchi AM; Rauch F; Jacob P; McCormick A; McMillan HJ; Matzinger MA; Ward LM Osteoporos Int; 2012 Nov; 23(11):2703-11. PubMed ID: 22297733 [TBL] [Abstract][Full Text] [Related]
16. Treatment for osteoporosis in people with ß-thalassaemia. Bhardwaj A; Swe KM; Sinha NK; Osunkwo I Cochrane Database Syst Rev; 2016 Mar; 3():CD010429. PubMed ID: 26964506 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Avenell A; Mak JC; O'Connell D Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD000227. PubMed ID: 24729336 [TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Manzur AY; Kuntzer T; Pike M; Swan A Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215 [TBL] [Abstract][Full Text] [Related]
19. Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline. Garegnani L; Hyland M; Roson Rodriguez P; Escobar Liquitay CM; Franco JV Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013720. PubMed ID: 34850383 [TBL] [Abstract][Full Text] [Related]